Braicu E. I. et al. [55] evaluated the diagnostic value of a panel of tests consisting of USG, HE4, CA125 and ROMA, both to detect ovarian cancer in patients over 18 years of age (N = 965) and to distinguish benign and malignant adnexal tumours. This evidence concerns the gene WFDC2 and ovarian cancer.